Literature DB >> 15549392

Hereditary prostate cancer in Finland: fine-mapping validates 3p26 as a major predisposition locus.

Annika Rökman1, Agnes B Baffoe-Bonnie, Elizabeth Gillanders, Henna Fredriksson, Ville Autio, Tarja Ikonen, Kenneth D Gibbs, Marypat Jones, Derek Gildea, Diane Freas-Lutz, Carol Markey, Mika P Matikainen, Pasi A Koivisto, Teuvo L J Tammela, Olli P Kallioniemi, Jeffrey Trent, Joan E Bailey-Wilson, Johanna Schleutker.   

Abstract

In a recent genome-wide linkage (GWL) analysis of Finnish families at high risk for prostate cancer, we found two novel putative susceptibility loci at 3p25-p26 and 11q14. Here, we report the fine-mapping of these two critical regions at high resolution with 39 microsatellite markers in 16 families, including multiplex families that were not used in the GWL scan. The maximum multipoint HLOD was 3.39 at 3p26 and 1.42 at 11q14. The highest LOD scores were seen around markers D3S1270 and D3S4559 (alpha=0.89), covering approximately two megabases. The two known genes in this region CHL1 (cell adhesion molecule with homology to L1CAM) and CNTN6 (contactin 6) were screened for exonic mutations in the families showing the strongest linkage, but no disease-segregating sequence variants were observed. The recombination map pointed to a region proximal to the area of best linkage, suggesting that more genes may need to be investigated as candidates. These results provide strong evidence for the existence of a prostate cancer susceptibility gene at 3p26 in Finnish prostate cancer families. This locus has not been strongly linked with hereditary prostate cancer in other populations. However, the mildly positive 3p LOD scores in a recent GWL analysis of patients from the United States suggest that the locus may also be important in other populations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15549392     DOI: 10.1007/s00439-004-1214-7

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  17 in total

1.  Genome-wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families.

Authors:  Jianfeng Xu; Elizabeth M Gillanders; Sarah D Isaacs; Bao-Li Chang; Kathy E Wiley; S Lilly Zheng; MaryPat Jones; Derek Gildea; Erica Riedesel; Julie Albertus; Diana Freas-Lutz; Carol Markey; Deborah A Meyers; Patrick C Walsh; Jeffrey M Trent; William B Isaacs
Journal:  Prostate       Date:  2003-12-01       Impact factor: 4.104

2.  Solid-phase minisequencing as a tool to detect DNA polymorphism.

Authors:  A C Syvänen
Journal:  Methods Mol Biol       Date:  1998

Review 3.  Molecular background of the Finnish disease heritage.

Authors:  L Peltonen
Journal:  Ann Med       Date:  1997-12       Impact factor: 4.709

4.  A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease.

Authors:  J Schleutker; M Matikainen; J Smith; P Koivisto; A Baffoe-Bonnie; T Kainu; E Gillanders; R Sankila; E Pukkala; J Carpten; D Stephan; T Tammela; M Brownstein; J Bailey-Wilson; J Trent; O P Kallioniemi
Journal:  Clin Cancer Res       Date:  2000-12       Impact factor: 12.531

5.  Germline mutations in the ribonuclease L gene in families showing linkage with HPC1.

Authors:  J Carpten; N Nupponen; S Isaacs; R Sood; C Robbins; J Xu; M Faruque; T Moses; C Ewing; E Gillanders; P Hu; P Bujnovszky; I Makalowska; A Baffoe-Bonnie; D Faith; J Smith; D Stephan; K Wiley; M Brownstein; D Gildea; B Kelly; R Jenkins; G Hostetter; M Matikainen; J Schleutker; K Klinger; T Connors; Y Xiang; Z Wang; A De Marzo; N Papadopoulos; O-P Kallioniemi; R Burk; D Meyers; H Grönberg; P Meltzer; R Silverman; J Bailey-Wilson; P Walsh; W Isaacs; J Trent
Journal:  Nat Genet       Date:  2002-01-22       Impact factor: 38.330

6.  Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics.

Authors:  J Xu
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

Review 7.  Human population genetics: lessons from Finland.

Authors:  J Kere
Journal:  Annu Rev Genomics Hum Genet       Date:  2001       Impact factor: 8.929

8.  A candidate prostate cancer susceptibility gene at chromosome 17p.

Authors:  S V Tavtigian; J Simard; D H Teng; V Abtin; M Baumgard; A Beck; N J Camp; A R Carillo; Y Chen; P Dayananth; M Desrochers; M Dumont; J M Farnham; D Frank; C Frye; S Ghaffari; J S Gupte; R Hu; D Iliev; T Janecki; E N Kort; K E Laity; A Leavitt; G Leblanc; J McArthur-Morrison; A Pederson; B Penn; K T Peterson; J E Reid; S Richards; M Schroeder; R Smith; S C Snyder; B Swedlund; J Swensen; A Thomas; M Tranchant; A M Woodland; F Labrie; M H Skolnick; S Neuhausen; J Rommens; L A Cannon-Albright
Journal:  Nat Genet       Date:  2001-02       Impact factor: 38.330

9.  Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk.

Authors:  Jianfeng Xu; S Lilly Zheng; Akira Komiya; Josyf C Mychaleckyj; Sarah D Isaacs; Jennifer J Hu; David Sterling; Ethan M Lange; Gregory A Hawkins; Aubrey Turner; Charles M Ewing; Dennis A Faith; Jill R Johnson; Hiroyoshi Suzuki; Piroska Bujnovszky; Kathleen E Wiley; Angelo M DeMarzo; G Steven Bova; Baoli Chang; M Craig Hall; David L McCullough; Alan W Partin; Vahan S Kassabian; John D Carpten; Joan E Bailey-Wilson; Jeffrey M Trent; Jill Ohar; Eugene R Bleecker; Patrick C Walsh; William B Isaacs; Deborah A Meyers
Journal:  Nat Genet       Date:  2002-09-16       Impact factor: 38.330

10.  Genome-wide scan for linkage in finnish hereditary prostate cancer (HPC) families identifies novel susceptibility loci at 11q14 and 3p25-26.

Authors:  Johanna Schleutker; Agnes B Baffoe-Bonnie; Elizabeth Gillanders; Tommi Kainu; Mary-Pat Jones; Diana Freas-Lutz; Carol Markey; Derek Gildea; Erica Riedesel; Julie Albertus; Kenneth D Gibbs; Mika Matikainen; Pasi A Koivisto; Teuvo Tammela; Joan E Bailey-Wilson; Jeffrey M Trent; Olli-P Kallioniemi
Journal:  Prostate       Date:  2003-12-01       Impact factor: 4.104

View more
  8 in total

Review 1.  Prostate cancer susceptibility loci: finding the genes.

Authors:  Elanie A Ostrander; Bo Johannesson
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

2.  Genome-wide linkage scan for prostate cancer susceptibility in Finland: evidence for a novel locus on 2q37.3 and confirmation of signal on 17q21-q22.

Authors:  Cheryl D Cropp; Claire L Simpson; Tiina Wahlfors; Nati Ha; Asha George; MaryPat S Jones; Ursula Harper; Damaris Ponciano-Jackson; Tiffany A Green; Teuvo L J Tammela; Joan Bailey-Wilson; Johanna Schleutker
Journal:  Int J Cancer       Date:  2011-04-20       Impact factor: 7.396

Review 3.  Tumor suppressor genes on frequently deleted chromosome 3p in nasopharyngeal carcinoma.

Authors:  Juan Chen; Li Fu; Li-Yi Zhang; Dora L Kwong; Li Yan; Xin-Yuan Guan
Journal:  Chin J Cancer       Date:  2012-02-24

4.  Differential expression of CHL1 gene during development of major human cancers.

Authors:  Vera N Senchenko; George S Krasnov; Alexey A Dmitriev; Anna V Kudryavtseva; Ekaterina A Anedchenko; Eleonora A Braga; Irina V Pronina; Tatiana T Kondratieva; Sergey V Ivanov; Eugene R Zabarovsky; Michael I Lerman
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240

5.  Next generation mapping reveals novel large genomic rearrangements in prostate cancer.

Authors:  Weerachai Jaratlerdsiri; Eva K F Chan; Desiree C Petersen; Claire Yang; Peter I Croucher; M S Riana Bornman; Palak Sheth; Vanessa M Hayes
Journal:  Oncotarget       Date:  2017-04-04

6.  CHL1 and NrCAM are Primarily Expressed in Low Grade Pediatric Neuroblastoma.

Authors:  Robin Wachowiak; Steffi Mayer; Anne Suttkus; Illya Martynov; Martin Lacher; Nathaniel Melling; Jakob R Izbicki; Michael Tachezy
Journal:  Open Med (Wars)       Date:  2019-12-31

7.  Commonalities in Development of Pure Breeds and Population Isolates Revealed in the Genome of the Sardinian Fonni's Dog.

Authors:  Dayna L Dreger; Brian W Davis; Raffaella Cocco; Sara Sechi; Alessandro Di Cerbo; Heidi G Parker; Michele Polli; Stefano P Marelli; Paola Crepaldi; Elaine A Ostrander
Journal:  Genetics       Date:  2016-08-12       Impact factor: 4.562

8.  CHL1 suppresses tumor growth and metastasis in nasopharyngeal carcinoma by repressing PI3K/AKT signaling pathway via interaction with Integrin β1 and Merlin.

Authors:  Juan Chen; Chen Jiang; Li Fu; Cai-Lei Zhu; Yan-Qun Xiang; Ling-Xi Jiang; Qian Chen; Wai Man Liu; Jin-Na Chen; Li-Yi Zhang; Ming Liu; Chao Chen; Hong Tang; Bo Wang; Sai Wah Tsao; Dora Lai-Wan Kwong; Xin-Yuan Guan
Journal:  Int J Biol Sci       Date:  2019-07-11       Impact factor: 6.580

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.